Pediatric patients transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Transplants Liver Antilymphocyte Serum Hematopoietic Stem Cells Kidney T-Lymphocytes Bone Marrow Cells Bone Marrow Portal Vein Stem Cells Cells, Cultured Fetal Blood Hepatic Artery Allografts

Organisms6

Transplantation Chimera Rats, Inbred Lew Mice, Inbred C57BL Mice, Inbred BALB C Chimera Radiation Chimera

Diseases55

Graft vs Host Disease Postoperative Complications Liver Failure Recurrence Hematologic Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Liver Diseases Acute Disease Kidney Failure, Chronic Leukemia Cadaver Anemia, Aplastic Cytomegalovirus Infections Heart Defects, Congenital Leukemia, Myeloid, Acute Bronchiolitis Obliterans Blood Group Incompatibility Biliary Atresia Burns Neoplasms End Stage Liver Disease Hepatic Veno-Occlusive Disease Infection Hematologic Diseases Lymphoma, Non-Hodgkin Liver Cirrhosis Mycoses Chronic Disease Brain Death Liver Failure, Acute Multiple Myeloma Kidney Diseases Hodgkin Disease Primary Graft Dysfunction Delayed Graft Function Liver Neoplasms Diabetes Mellitus, Type 1 Disease Models, Animal Lymphoproliferative Disorders Leukemia, Myeloid Cerebellar Neoplasms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Bacterial Infections Medulloblastoma Carcinoma, Hepatocellular Hepatoblastoma Disease Progression Reperfusion Injury Lymphoma Brain Neoplasms Neoplasm Recurrence, Local Severe Combined Immunodeficiency Renal Insufficiency Respiratory Tract Infections

Chemicals and Drugs31

Immunosuppressive Agents Tacrolimus Cyclosporine Busulfan HLA Antigens Cyclophosphamide Antilymphocyte Serum Mycophenolic Acid Myeloablative Agonists Biological Markers Melphalan Prednisone ABO Blood-Group System Granulocyte Colony-Stimulating Factor Creatinine Anti-Bacterial Agents Antigens, CD34 Cytarabine Etoposide Isoantibodies Arabinonucleosides Antineoplastic Agents Antibodies, Monoclonal Methylprednisolone Vidarabine Azathioprine Antiviral Agents Organ Preservation Solutions Vincristine Cyclosporins Bilirubin

Analytical, Diagnostic and Therapeutic Techniques and Equipment117

Liver Transplantation Transplantation, Homologous Kidney Transplantation Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Organ Transplantation Treatment Outcome Pancreas Transplantation Transplantation Retrospective Studies Islets of Langerhans Transplantation Cell Transplantation Cord Blood Stem Cell Transplantation Transplantation, Isogeneic Transplantation, Heterotopic Heart-Lung Transplantation Peripheral Blood Stem Cell Transplantation Follow-Up Studies Histocompatibility Testing Immunosuppression Fetal Tissue Transplantation Survival Rate Skin Transplantation Survival Analysis Prospective Studies Transplantation, Heterologous Mesenchymal Stem Cell Transplantation Corneal Transplantation Risk Factors Tissue Transplantation Whole-Body Irradiation Prognosis Combined Modality Therapy Brain Tissue Transplantation Facial Transplantation Donor Selection Organ Preservation Incidence Remission Induction Postoperative Period Disease-Free Survival Cohort Studies Biopsy Patient Selection Severity of Illness Index Antineoplastic Combined Chemotherapy Protocols Hand Transplantation Tissue and Organ Harvesting Body Surface Area Risk Assessment Hematopoietic Stem Cell Mobilization Extracorporeal Membrane Oxygenation Drug Administration Schedule Neoplasm Transplantation Multivariate Analysis Feasibility Studies Fatal Outcome Predictive Value of Tests Postoperative Care Salvage Therapy Polymerase Chain Reaction Drug Dosage Calculations Kaplan-Meier Estimate Sensitivity and Specificity Reoperation Magnetic Resonance Imaging Tomography, X-Ray Computed Treatment Failure Lymphocyte Transfusion Actuarial Analysis Lymphocyte Depletion Blood Transfusion Drug Therapy, Combination Infusions, Intravenous Cold Ischemia Preanesthetic Medication Renal Dialysis Anastomosis, Surgical Plasmapheresis Leukapheresis Hepatectomy Flow Cytometry Reproducibility of Results Case-Control Studies Disease Models, Animal Registries Liver Function Tests Models, Animal Preoperative Care Tonsillectomy Pilot Projects Proportional Hazards Models Heart-Assist Devices Area Under Curve Respiration, Artificial Probability Platelet Count Anesthesia, Caudal Statistics, Nonparametric Immunohistochemistry Administration, Oral Intubation, Intratracheal Prevalence Graft Enhancement, Immunologic Bone Marrow Purging Intraoperative Period Kidney Function Tests Cryopreservation Chi-Square Distribution Leukocyte Transfusion Length of Stay Warm Ischemia

Psychiatry and Psychology1

Phenomena and Processes22

Graft Survival Graft Rejection Transplantation Immunology Time Factors Transplantation Tolerance Histocompatibility Immunocompromised Host Body Surface Area Chimerism Cell Differentiation Graft vs Leukemia Effect Sensitivity and Specificity Graft vs Tumor Effect Dose-Response Relationship, Drug Hematopoiesis Area Under Curve Probability Graft vs Host Reaction Platelet Count Immune Tolerance Radiation Chimera Chi-Square Distribution

Disciplines and Occupations3

Pediatrics Immunohistochemistry Pediatric Nursing

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science5

Survival Rate Incidence Fatal Outcome Registries Prevalence

Named Groups6

Tissue Donors Living Donors Infant, Newborn Child, Hospitalized Unrelated Donors Siblings

Health Care43

Treatment Outcome Retrospective Studies Follow-Up Studies Tissue and Organ Procurement Survival Rate Survival Analysis Waiting Lists Prospective Studies Risk Factors Hospitals, Pediatric Age Factors Intensive Care Units, Pediatric Donor Selection Incidence Postoperative Period Disease-Free Survival Cohort Studies Patient Selection Severity of Illness Index Risk Assessment Multivariate Analysis Feasibility Studies Fatal Outcome Predictive Value of Tests Postoperative Care Kaplan-Meier Estimate Sensitivity and Specificity Treatment Failure Actuarial Analysis Reproducibility of Results Case-Control Studies Registries Preoperative Care Pilot Projects Proportional Hazards Models Area Under Curve Probability Statistics, Nonparametric Prevalence Pediatric Nursing Intraoperative Period Chi-Square Distribution Length of Stay

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Liver Transplantation Transplantation, Homologous Kidney Transplantation Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Graft Survival Organ Transplantation Graft Rejection Treatment Outcome Pancreas Transplantation Transplantation Tissue Donors Retrospective Studies Islets of Langerhans Transplantation Transplantation Immunology Cell Transplantation Transplantation Chimera Immunosuppressive Agents Graft vs Host Disease Living Donors Cord Blood Stem Cell Transplantation Transplantation, Isogeneic Time Factors Transplantation, Heterotopic Heart-Lung Transplantation Peripheral Blood Stem Cell Transplantation Postoperative Complications Follow-Up Studies Liver Failure Tissue and Organ Procurement Recurrence Transplantation Tolerance Histocompatibility Testing Immunosuppression Infant, Newborn Fetal Tissue Transplantation Pediatrics Hematologic Neoplasms Survival Rate Skin Transplantation Tacrolimus Survival Analysis Waiting Lists Prospective Studies Transplantation, Heterologous Cyclosporine Mesenchymal Stem Cell Transplantation Corneal Transplantation Histocompatibility Risk Factors Tissue Transplantation Precursor Cell Lymphoblastic Leukemia-Lymphoma Whole-Body Irradiation Liver Diseases Hospitals, Pediatric Acute Disease Kidney Failure, Chronic Leukemia Cadaver Age Factors Prognosis Combined Modality Therapy Brain Tissue Transplantation Intensive Care Units, Pediatric Facial Transplantation Donor Selection Organ Preservation Incidence Anemia, Aplastic Busulfan Remission Induction Postoperative Period Transplants Immunocompromised Host Disease-Free Survival Cohort Studies HLA Antigens Biopsy Cytomegalovirus Infections Cyclophosphamide Heart Defects, Congenital Leukemia, Myeloid, Acute Bronchiolitis Obliterans Patient Selection Severity of Illness Index Antineoplastic Combined Chemotherapy Protocols Liver Antilymphocyte Serum Hand Transplantation Blood Group Incompatibility Biliary Atresia Mycophenolic Acid Burns Myeloablative Agonists Hematopoietic Stem Cells

No FAQ available that match "pediatric patients transplantation"